SETTLEMENT AGREEMENTSettlement Agreement • September 8th, 2010 • Accipiter Capital Management, LLC • Services-testing laboratories • New York
THIS SETTLEMENT AGREEMENT (“Agreement”), dated as of September 3, 2010, is made by and between Orchid Cellmark Inc., a Delaware corporation (“ORCH” or the “Company”), and the entities and natural persons listed on Schedule A hereto (collectively, the “Accipiter Group”) (each of the Company and the Accipiter Group, a “Party” to this Agreement, and collectively, the “Parties”).
JOINT FILING AGREEMENTJoint Filing Agreement • September 8th, 2010 • Accipiter Capital Management, LLC • Services-testing laboratories
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of Amendment No. 2 to the Schedule 13D originally filed on March 10, 2010 (including additional amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Orchid Cellmark Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
